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Abstract
This study examined the effects of a smoking cessation program using vouchers
as reinforcers with individuals with traumatic brain injury and a history of substance
abuse. The intervention was conducted at a residential facility that houses individuals
with Traumatic Brain Injury (TBI). Vouchers were delivered contingent on reductions of
carbon monoxide (CO) samples of 5 ppm or less across a shaping phase, and an
abstinence induction phase. A standard pay phase was added at the end of the study to
examine the effects of a standardized reinforcement scale with the abstinence criterion set
at 8 ppm or less. Reductions in CO were not robust in the shaping and abstinence
induction phase. The standard pay schedule showed some improvements in CO levels
with less variability for two of the three participants.
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Introduction
According to the CDC smoking is the leading cause of death in the U.S. From
1998 to 2008 smoking declined to 20.6%, which was a 3.5% reduction from the previous
years (Center for Disease Control, 2009). Men in the United States have a smoking
prevalence rate of 23.1% and women 18.3%. Smoking carries with it a number of health
risks which include various types of cancer. It has been linked to kidney, laryngeal, lung,
cervical, bladder, esophageal, pancreatic, and oral cancer (CDC, 2009). Along with these
risks include heart disease, cerebrovascular atherosclerosis, and a number of respiratory
diseases (CDC, 2009). Between 2000 and 2004, smoking resulted in 269,655 deaths
among men and 173,940 deaths among women in the United States (Adhikarri, Khende,
Malarcher, Pechacek, &Vong, 2009). Despite these risks, between 2007 and 2008 there
was a modest increase in smoking which stunted the nationwide Healthy People 2010
objective of reducing the prevalence of cigarette smoking to < 12% among adults (CDC,
2009). And although adolescent smoking use declined from 1997 to 2003, the prevalence
rate remained stable with 20% of high school students still smoking cigarettes.
With the many health risks associated with smoking, a number of cessation
treatments have been tested showing positive effects with short and long term abstinence
among adults (Khazall, Cornux, Bilancioni, & Zullino, 2006; Kornitzer, Boutsen,
Dramaix, Thijs, & Gustavsson, 1995; Oncken et al., 2006; Schneider et al., 1995; Schnoll
et al., 2010; Stapleton et al., 1995). Such treatments have included medications such as
nicotine replacement therapies (NRT) that incorporate the use of lozenges, nicotine
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inhalers, nicotine nasal sprays, nicotine patches or nicotine gum to help reduce smoking
(Aveyard, Johnson, Fillingham, Parsons, & Murphy, 2008; Cooney et al., 2009;
Schneider et al., 1995; Shiffman et al., 2002; Sutherland & Stapleton, 1992). Some NRT
products are designed to show an immediate effect by impacting the amount of craving
an individual encounters. While others are designed to release a continuous supply of
nicotine throughout a 24 hour period and provide a more gradual effect that has led to
abstinence being verified at one year follow up (Shiffman et al., 2002).
Additional medications have included antidepressants such as bupropion and
nortriptyline, which have shown long term abstinence (Fossati et al., 2007). Varenicline,
a nicotine blocker, has shown to be effective with higher continuous abstinent rates in
comparison to a bupropion and placebo group at 52 week follow-up (Jorensby et al.,
2006). Topiramate, an anticonvulsant medication, has shown more gender specific
effects in men with men four times more likely to quit when treated with Topiramate than
men in the placebo group (Anthenelli, Blom, McElroy, & Keck, 2008).
Some other treatments have included combinations of NRT with components
such as practitioner’s advice and educational material, and have demonstrated positive
effects for abstinence (Russell, Merriman, Stapleton, & Taylor, 1983). This is further
supported by later studies that have implemented combination approaches and also
demonstrated positive effects (Buchkremer, Bents, Horstmann, Opitz, & Tolle, 1989;
Puska et al., 1995; Russell, Merriman, Stapleton, & Taylor, 1983). By themselves,
certain NRTs may be more effective in conjunction with behavioral support that includes
counseling and advice from a nurse practitioner (Leischow, Ranger-Moore, Muramoto, &
Mathews, 2004). Buchkremer et al. (1989) implemented a combination approach with a
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behavioral component that included a deposit contract designed to assure attendance in
small group training sessions and showed efficacy with reductions in smoking.
A number of studies have included contingency management programs using
money and have yielded positive results as well. Rand, Stitzer, Bigelow, and Mead
(1989) implemented a combination approach that included contingency management in
conjunction with frequent monitoring in a between-group design at a worksite delivering
payment contingent on lower levels of CO. This resulted in a delay in relapse that was
significantly different than the placebo and the noncontingent group (Rand et al., 1989).
In another study Stitzer, Rand, Bigelow and Mead (1986) introduced a contingency
management intervention that utilized a sliding scale for money earned contingent on
reductions in CO level. In the final two weeks of the study participants had the
opportunity to earn $12 a day if they were completely abstinent and provided breath
samples three times a day. Results demonstrated that most of the participants were
willing to attempt abstinence during the last two weeks and that 80.5% were breathing <
8 ppm in CO demonstrating a significant reduction from pre-study readings (Stitzer et al.,
1986). In a more recent study done by Reynolds, Dallery, Schroff, Patak, and Leraas
(2008), researchers monitored four adolescents for smoking abstinence and found that all
participants achieved prolonged abstinence when money was delivered contingent on CO
levels < 5 ppm.
In other instances vouchers have been shown to be effective. Dunn, Sigmon,
Thomas, Heil, and Higgins (2008) found a voucher based contingency management
program to be effective in curbing smoking with methadone-maintained individuals.
They also found a greater percentage of abstinent samples were provided with the
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contingent group than the noncontingent control group (Dunn et al., 2008). Other novel
approaches have included the use of drawings as well as the use of deposit contracts.
Alessi, Petry, and Urso (2008) implemented a contingency management intervention with
residents that involved the earning of draws in a raffle drawing with each negative CO
reading. Results showed decreases in cigarettes smoked and reduced levels in CO with
residents entering a substance abuse program (Alessi et al., 2008). Dallery, Meredith,
and Glenn (2008) used deposit contracts that were demonstrated to be feasible in
delivering reinforcement for abstinence.
Approximately 200,000 individuals with mental health illness die annually of
tobacco related disease. For people with mental illness and a history of substance abuse,
nicotine addiction is generally much more severe than in the general public (Schroeder &
Morris, 2010). Additionally, 77%-93% of individuals in substance abuse clinics use
tobacco products (Schroeder & Morris, 2010). Individuals with mental illness/substance
use disorder also have a tendency to die 25 years earlier than the general population as a
result of smoking and previous existing conditions (Schroeder & Morris, 2010). In
addition to the health consequences, smoking places a financial toll on individuals with
mental illness and substance abuse problems by impacting the way money is managed.
Approximately 27% spend their money on smoking (Schroeder & Morris, 2010). Part of
becoming more independent involves having the ability to manage money wisely.
Without money management skills, integration back into the community becomes more
difficult.
With populations with mental illness/substance abuse, the success of smoking
cessation may be predicted by symptoms of comorbid diagnosis of depression. Niaura et
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al. (2001) in one study examined pre-treatment symptoms of depression and the time to
relapse to see if symptoms could predict the time to relapse. Researchers concluded that
minimal symptoms of depression, described as pre-treatment mood, were enough to
predict the survival of quit attempts. But life time history of depression did not (Niaura
et al., 2001). Treatments for individuals with mental illness have included many of the
FDA approved medications that are typically used by the general population (Schroeder
& Morris, 2010). Because individuals with mental illness or substance dependence often
have more severe nicotine addictions, individuals also require more intensive treatment
that may include higher doses and longer durations of treatment, and potentially more
combinations of interventions that are included in a highly individualized treatment plan
(Schroeder & Morris, 2010). Despite the impact smoking has on these individuals,
tobacco control with this population has been insufficient and requires further research
(Schroeder & Morris, 2010).
Furthermore most research on smoking cessation has focused on interventions
with typically developing adults. Much of the research on smoking also focuses on
surveys determining variables predicating smoking prevalence rather than interventions
(Fagan, Brook, Rubenstone, & Zhang, 2005; Shiffman, Brockwell, Pillitteri, & Gitchell,
2008; Slomkowski, Rende, Novak, Lloyd-Richardson, & Niaura, 2004). No known
research has focused on adult smokers with traumatic brain injury (TBI) who may also be
dually diagnosed with psychiatric illness and a history of substance abuse. Further
research for this population is needed considering that many individuals with comorbid
substance use disorder are also addicted to nicotine. Individuals with TBI often have
other diagnoses including Post Traumatic Stress Disorder (PTSD) where symptoms might
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include intense fear and anxiety, and insomnia (Lew et al., 2008; Parcell et al., 2006). In
one study insomnia was reported in 80% of participants with TBI (Parcell et al., 2006).
Among individuals with TBI, substance use disorder is found to be more severe and
many also experience higher rates of depression, and anxiety with increases in suicide
attempts (Felde, Westermeyer, & Thuras, 2006). Many prescribed medications for
smoking cessation have side-effects that may resemble symptoms associated with
comorbidity. For example bupropion, which is generally prescribed as an antidepressant
and has been approved for use in smoking cessation, has been known to cause reactions
such as sleeplessness, panic attacks, depression, irritability, and seizures which are
common among individuals with TBI (“Side effects”, 2010). Nortriptyline is another
common antidepressant medication that shares some of the same side-effects that include
changes in mood, suicidal ideations, trouble sleeping with the addition of heart pounding
(“Side effects”, 2010). These types of effects can lead to greater difficulties with
independence and general well-being and also impact the outcome of any treatment. In
cases in which prescribed medications can not be used, alternatives could include
nicotine replacement therapies such as nicotine gum or nicotine patches which have been
demonstrated to be effective and even more effective as combination treatments (Puska et
al., 1995). However, these treatments also have side-effects such as skin irritation, mouth
and throat soreness, nausea, vomiting, and coughing. More serious side-effects may also
include heart palpitations and chest pains along with insomnia (Mills, Lockhart, Wilson,
& Ebbert, 2010). Even if side-effects were controlled for individuals with TBI, the use of
nicotine replacement therapies may be contraindicated if individuals have preexisting
medical conditions (“Side-effects”, 2010).
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Other options are needed for individuals with TBI. Contingency management
programs have been effective in reducing CO levels in individuals who smoke without
the potential harm associated with medications. As described earlier, many studies have
examined the use of vouchers, lottery tickets, and raffle drawings and in many cases these
have been shown to be effective for smoking cessation (Alessi et al., 2008; Dunn et al.,
2008; Neese, 2009). This study extends previous research on smoking cessation studies
that have used vouchers as reinforcers and also incorporates other behavioral components
that have been used to decrease smoking such as frequent monitoring, self-monitoring,
and vouchers. The main purpose of this study was to examine the efficacy of using
vouchers in a smoking cessation intervention with individuals with TBI and a history of
smoking.
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Method
Participants
Three participants, 1 female and 2 male with traumatic brain injury (TBI) and
with a history of at least 1 year of smoking participated in the study. Amanda was a 36year-old Caucasian female who was a left leg amputee which was the result of an
automobile accident. Amanda was diagnosed with bipolar disorder, chronic anemia, and
TBI. Her past diagnoses have included substance use disorder. Amanda was undergoing
treatment for pain that she was experiencing in her phantom limb and had difficulty
walking with her prosthetic. She spent most of her time ambulating using her wheel
chair. Amanda reportedly had smoked for about 20 years starting at the age of 15 and had
attempted quitting at least once. In the past Amanda had used the patch and Chantix- a
prescribed medication that blocks the nicotine receptors of neurons. Amanda reportedly
smoked approximately 22 cigarettes a day. Harry was a 45-year-old Asian American
male diagnosed with a TBI, substance use disorder and type II diabetes. His TBI was
sustained from an automobile accident. As a result he had residual deficits to his short
term memory, concentration, and dysphasia. His drug use had included alcohol, opiates,
cocaine and marijuana. Harry reportedly had never attempted quitting smoking and
never used any nicotine replacement therapy. Harry reportedly smoked about 10
cigarettes a day and had smoked for 27 years. Mark was a 34-year-old Caucasian male
who sustained a TBI after falling from a wall while on active duty. His past diagnoses
had included bipolar disorder and substance use disorder. His drug use included opioids,
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cocaine, marijuana, alcohol, and heroin. In the past Mark had made quit attempts at least
4 times and had used the patch as part of his nicotine replacement therapy. Mark
reportedly smoked 16-20 cigarettes a day and had smoked for 22 years. The residential
facility, in which all three participants resided, assessed functioning level using the
Rehabilitations Institute of Chicago Functional Assessment Scale (RIC-FAS). Based off
of the RIC-FAS, participants had a minimum of mild to moderate impairment and a
rating of 4-5 on the memory scale. Individuals who have a rating of 4 require minimal
prompting, and they recognize and remember 75-90% of the time. Participants who
score a 5 require prompting only under stressful conditions, but no more than 10% of the
time. Participants also had a minimum baseline CO level between 10 and 15 parts per
million (ppm) and were not currently part of a smoking cessation program.
Setting
The setting was at a residential facility that housed 20 residents with TBI. In
the residential facility there were approximately 200 employees with 8-10 care takers
assigned to each shift. Many of the residents were part of a work hardening program in
which they worked at the residential housing facility earning money doing odd jobs
which included grounds keeping, cleaning, and stuffing brochures. As a part of their
program residents undergo inpatient treatment which includes cognitive therapy,
counseling, physical training, and behavioral services. Behavioral services are
implemented as part of a comprehensive program designed to reduce problem behaviors
that may include verbal outbursts, elopement, drug seeking, and physical aggression.
Additionally behavioral services are provided to facilitate the acquisition of skills for
independence with the eventual goal for residents to be able to live on their own. Two of
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the participants Amanda and Mark lived in apartments with roommates on the residential
campus. Harry lived in a group home with one other client not participating in the study.
Interview
Prior to the start of intervention, each participant underwent a brief counseling
session provided by the board certified behavior analyst at the facility via a power point
presentation format that covered setting a quit date, tips on gaining support from friends
and family, planning for challenges, and removing triggers to smoking in the
environment using the Clearing the Air: Quit Smoking Today booklet (attached to
appendices). At the conclusion of the counseling session, motivation for quitting was
assessed using the University of Rhode Island Change Assessment Long Form (URICA)
(Appendix 1) (University of Rhode Island Cancer Prevention Research [URICA], 1991).
The addition of a counseling session with the booklet and the assessment for motivation
was based off of an earlier study by Glenn and Dallery (2007). Demographic information
was gathered through a review of the participants’ file. Information that was gathered
included gender, age, current diagnoses, race, history of smoking, age of first cigarette,
and current medical conditions.
Withdrawal, craving, and nicotine dependence can be important factors for
long term abstinence and relapse and were assessed using different assessment scales.
Nicotine dependence was assessed during baseline using the Fagerstrom Test for
Nicotine Dependence (Appendix 2) to assure dependence at the start of the study
(Fagerstrom, Heatherton, & Kozlowski, 1991).Withdrawal severity is a predictor of
relapse and was tracked throughout the study. Withdrawal was assessed at the beginning
and end of baseline conditions, at the end of the shaping phase, at the end of the
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abstinence induction phase, and at the end of the standard pay phases using the
Minnesota Withdrawal Scale Revised (MWSR) (Appendix 3) (Hughes & Hatsukami,
2008). Craving severity is also important for predicting long term abstinence and was
included on the scale as part of the total score (MWSR).
CO Monitoring
Carbon monoxide (CO) was measured using the Bedfont Micro-Smokerlyzer.
The CO monitor was tested for validity and reliability by having a non-participant nonsmoker exhale into the monitor twice before the start of baseline and once per week
throughout the study. The two readings for the non-smoker were compared to each other
to determine reliability. The two readings for the smoker were also compared to each
other to determine the reliability of the readings. A comparison of readings between
smoker and non-smoker was conducted to determine validity. If the smoker’s reading
was higher than the non-smoker’s reading for both exhalations then this would indicate
instrument validity. To get an accurate reading the participant inhaled and held their
breath as the device counted down from 15 s. During the last three seconds the device
beeped briefly for the first two seconds and beeped one continuous tone for the third
second. At the end of the beep the participant placed their mouth onto the cardboard
mouth piece attached to a plastic D-piece on the front of the CO monitor and exhaled into
the device continuously. After the participant completely exhaled into the device, a
reading was delivered in parts per million (ppm) on the display located on the front of the
monitor.
Participants provided 4 CO readings each day separated by at least 5 hrs and
not to exceed 8 hrs in between readings (Reynolds et al., 2008). This requirement was
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included because the half-life of CO is 4 to 5 hrs. After 5 hrs trace amounts of CO can be
detected at up to 8 hrs. One CO sample was given in the morning between 8 am and 9
am. The second CO sample was given in the afternoon between 12 pm and 2 pm. The
third CO sample was taken early evening between 5 pm and 7 pm. And the last CO
sample was taken prior to each participant going to bed. For participant 1 her last sample
was taken at 9 pm. For participant 2 and 3 their samples were taken between 10 pm and
11 pm before they went to bed.
Staff Training
A task-analysis for the CO monitor is located in Appendix 4. Prior to the
study, staff members and research assistants were trained to use the CO monitor by
practicing on themselves with the trainer. The use of the CO monitor was modeled by
the trainer before assistants and staff members practiced on themselves. Staff members
and research assistants were graded on the completion of the steps in the task analysis
and required to retest until 100% had been achieved. Research assistants and staff
members were trained on data documentation which included the CO level, the amount of
money a participant earned per CO reading and the serial number of each of the vouchers.
Assessment tools (i.e. the URICA, MWSR, and Fagerstrom) were administered by the
researcher and the BCBA at the facility. Research assistants and staff members all scored
100% after training.
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Experimental Design
The study used a multiple baseline design across participants with an
ABCADA format, which included a baseline (A), shaping condition with an increasing
pay scale (B), abstinence induction condition (C) and a standard pay scale (D).
Baseline
Throughout all phases of the study, staff members were only allowed to smoke
in areas out of sight of the participants. Incidentally a company wide non-smoking policy
was also put into place for all employees. In baseline, participants in the study were
allowed to continue smoking as they normally would. There were no consequences
delivered for smoking cigarettes. CO levels were taken 4 times a day as described
previously.
Shaping
Vouchers had values assigned to them with the amount displayed on the front.
To help reduce the risk of participants falsifying the values of the vouchers, the vouchers
each had their own serial number. For their first sample participants were given a
voucher for a CO sample lower than their baseline mean. For each additional sample a
voucher was delivered if their CO sample was less than their previous sample.
Participants’ initial CO level below baseline mean resulted in a voucher worth $2.00.
Each successive reduction resulted in a .25 increase until CO levels stabilized at or below
5 ppm at which time vouchers were no longer delivered for successive reductions
(Reynolds et al., 2008). For example the initial CO sample was $2.00. The second CO
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sample was $2.25. The third CO sample was $2.50. The fourth sample was $2.75. This
continued until the participant reached $5.75. Increases in CO levels before reaching 5
ppm, resulted in the voucher amount resetting to the initial amount of $2.00 (Dunn et al.,
2008; Glenn & Dallery, 2007; Reynolds et al., 2008). The participants had the potential
of earning up to $62.00 during the shaping procedure. After an increase in CO,
participants had the opportunity to reinstate the voucher amount with 3 negative CO
readings (less than or equal to 5ppm) (Dunn et al., 2008; Reynolds et al., 2008).
Daily goals for reductions were based off of each participants’ average
baseline CO level and were established across four days so that on the fourth day the CO
level would be less than or equal to 5 ppm. Goals for each day were established by
reducing the baseline mean for each participant by 25% across four days. Bonuses were
assigned for achieving the predetermined goals within the specified time period. For
achieving the first goal the participant was able to earn $5. This amount increased in
increments of $5 with the accomplishment of each goal across the 4 days. For this
portion of the reinforcement contingency the participant had the potential of earning up to
$50 vouchers for reaching all of the goals. Participants were not able to earn bonuses
more than once. For example upon earning a bonus, the participant could not provide a
sample with a higher CO level then reduce the CO level again to earn the same bonus.
The purpose of this reinforcement schedule was to increase the likelihood of reductions
in CO occurring within the specified period of time. Without this contingency, it was
possible that participants could still earn vouchers in reductions in CO, but still not
achieve any of the predetermined goals.
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Additionally participants were provided feedback on their progress by the
research assistants and staff members administering the CO monitor. Feedback included
the provision of praise and congratulatory remarks if the participant reduced their CO
levels or corrective feedback if they did not reduce their CO levels. After the delivery of
a CO sample, participants were shown the CO reading and reminded of the criteria they
needed to meet in order to receive the bonus vouchers. Graphical feedback including
current performance, total earnings, and total available earnings was delivered twice a
day, once prior to the morning sample and once prior to the early evening sample.
Abstinence Induction
At the conclusion of the shaping phase the abstinence induction phase began.
Participants were given vouchers for providing a CO sample equal to or less than 5 ppm.
Voucher values during this phase equaled the last amount they were earning during the
shaping phase minus the bonus amounts. The induction phase lasted 10 days. This phase
was based upon an earlier study by Dallery et al. (2008). Because the most a participant
could earn per reduction in CO sample during the shaping phase was $5.75, during the
abstinence induction phase participants had the opportunity to earn up to $230.00 total if
they ended the shaping phase at $5.75. During the abstinence induction phase graphical
feedback was faded to once a day in the morning
Return to Baseline
As an evaluation of maintenance effects, following the abstinence induction
phase participants returned to the baseline condition. During this time participants were
allowed to continue smoking as they normally would. There were no consequences
delivered for smoking cigarettes.
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Standard Pay Schedule
As a result of a lack of intervention success and maintenance, the standard pay
schedule condition was added to evaluate the differences between an increasing scale of
reinforcement (shaping) and standard pay scale (abstinence induction and standard pay
condition with higher voucher value). This condition was similar to the abstinence
induction condition in that a flat amount was delivered contingent on the participant
achieving abstinence criterion. Additionally the abstinence criterion was changed to 8
ppm or less. During the standard pay condition the graphical feedback was given once a
day in the morning or early afternoon
Inter-Observer Agreement
A task analysis on the use of the CO monitor was used. Research assistants
collected inter- observer agreement (IOA) for 42% of the sessions for each participant
across all conditions to monitor the appropriate use of the CO monitor and the measure of
CO. Inter-observer agreement was calculated by dividing the number of agreements by
10 (total number of steps in the task analysis). An agreement was defined as the step
from the task analysis in which two observers recorded the step being followed correctly.
A disagreement was the extent to which both observers recorded differences in the step
being followed (i.e., one observer scored that the step was completed correctly while the
other observer recorded that the step was not completed correctly). The level of CO on
the monitor was recorded by two observers. Both observers needed to record the exact
number in ppm to be in agreement. IOA was 100% for the observed CO measure and
100% for the use of the CO monitor.
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Results
Across all three participants high variability was identified during baseline and
throughout the intervention (Fig 1). Upon the introduction of the shaping condition for
Amanda there was a gradual reduction in her CO levels. For Amanda, a decreasing trend
occurred beginning from the shaping condition and continuing to the first 6 samples of
the abstinence induction phase where sharp spikes in her CO level began to appear with
levels of 22 ppm, 20 ppm, and 18 ppm.

With a return to baseline, for Amanda CO

variability was less than the shaping and abstinence induction phase. Her performance
continued along an increasing trend and response variability returned to higher levels as
the standard pay condition was introduced.
During the introduction of the shaping condition for Harry a sharp decline in
his CO level was identified while Mark continued to show stability during his baseline
CO levels. Harry’s CO levels began to lose stability once the abstinence induction
condition was introduced. There was also an increasing trend with high variability
around level of responding beginning to approximate his baseline variability, with
increases appearing more gradual than Mark’s performance during the abstinence
induction condition. When Harry returned to baseline his CO levels continued to show
similar levels to the abstinence induction phase. For Harry the standard pay schedule
demonstrated reductions in CO levels but began to increase with the return to baseline.
Upon the introduction of the shaping condition for Mark his CO levels
gradually reduced . Mark’s CO reductions continued until the beginning of the
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abstinence induction condition in which increases in CO levels occurred for all three
participants. With the introduction of the abstinence induction condition Mark’s first CO
sample immediately increased to a level consistent with his baseline samples. This
continued with less variability than his baseline samples with his highest reading being
17 ppm in comparison to his highest reading during baseline being 22 ppm. Mark’s return
to baseline resulted in a reduction in variability which continued into the standard pay
condition.
Scores from the URICA (Table 2) for Mark indicate d his readiness to change
fell between the contemplation and the action stages with readiness to change being
highest with the action stage with a score of 32. His score for the contemplation stage
was 31. Lowest scores were 17 for the pre-contemplation stage and 27 for the
maintenance stage. Amanda’s highest score was in the contemplation stage with 33. Her
next highest was in the maintenance stage with 26 followed with action stage with 25 and
pre-contemplation with 11. Harry’s scores, similar to Amanda, were highest in the
contemplation stage with 31 which were followed by 27, 25, and 7 for the maintenance,
action, and pre-contemplation stages.

Participants together earned a total of $346 in the

study. Participants were all able to earn their $50 bonuses. Amanda earned a total of
$103.75. Harry earned a total of $153.00. And Mark earned $89.25 (See Table 3 for
details on earnings during each phase).
Craving scores for Mark started off at 4 during baseline then reduced to 2 in
the remaining conditions. For Amanda, her craving score started off at 4 during baseline
then reduced to 3 during the shaping phase. Her scores further reduced to 2 during the
abstinence induction phase and the baseline phase. During the standard pay phase, her
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score returned to 3 and stayed there during the return to baseline. Harry’s craving score
started off at 2 during the initial baseline then increased to 3 during the shaping phase.
His highest score of 4 occurred during the abstinence induction condition after which it
reduced to 3 during baseline and the standard pay phases. During baseline his scores
returned to 2 and remained there.
Items 1-9 were summed for withdrawal scores for all participants. For Mark
his score was 8 during baseline, which increased to 11 during the shaping phase and
reduced to 9 during the abstinence induction phase. During his second baseline his score
increased to 16 then returned to 9 in his standard pay phase. Amanda’s initial baseline
score was 20. Her scores reduced slightly to 16 during the shaping phase then returned to
20 during the abstinence induction phase. Following the abstinence induction phase was
the second baseline in which her score reduced to 12. During the standard pay condition
her withdrawal score increased to 22 and rose even further to 25 during the final baseline
phase. Harry’s score during the initial baseline was 20. His score reduced to 8 during the
shaping phase then rose again to 16 during the abstinence induction phase. A return to
baseline showed a slight reduction in withdrawal with a score of 15 and a further
reduction during the standard pay phase with a score of 12. During his final baseline his
withdrawal score rose back to 17. Fagerstrom scores for Mark, Amanda, and Harry were
3, 3, and 1.
Out of a total of 182 samples, Mark was able to provide 92% of the samples
missing 13. Out of a possible 174 samples, Amanda provided 94% of the samples
missing 9. Out of 180 total possible samples, Harry provided samples for 93% of them,
missing 11.
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Discussion
The purpose of the study was to extend research on smoking cessation
programs using voucher reinforcers for achieving reductions in smoking. Research
typically included a shaping condition and an abstinence induction condition. Schedules
of reinforcements usually involved the delivery of vouchers along an increasing scale or a
standard pay scale. In some studies the standard pay scale was used in the shaping phase
and in other studies the standard pay scale was used in the abstinence induction phase.
This study used an increasing scale as part of the shaping phase and a flat rate scale as
part of the abstinence induction phase. Research using this methodology has focused on
typical adults and adolescents that smoke. This study focused on a population of TBI
clients at a residential facility. The participants in this study all reached 5 ppm or less,
however, overall never consistently maintained the abstinence criteria. Amanda and Mark
both showed CO reductions during the shaping phase. Looking at their last phases and
comparing it with their initial baseline phases further reductions were observed. For
Mark a clear reduction in variability was identified in his last phase only after the criteria
for abstinence changed to 8 ppm. Amanda’s lower levels however appeared to be more
of a continuation of reductions observed in her second baseline indicating the need for
better experimental control. Harry also showed reductions once the criteria changed to 8
ppm. CO levels for him during the standard pay phase began to approximate his shaping
phase. The standard pay phase for Harry should have been continued for a longer period
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of time. Doing so would have given a better understanding of whether or not a reinforcer
contingency could produce reductions similar to Harry’s shaping phase.
Individuals with TBI, as a result of experiencing their injury, often exhibit a
number of complications related to psychiatric disorder. With depression, for example,
many experience sadness, irritability, fatigue, loss of sleep, psychomotor retardation,
difficulty concentrating and memory dysfunction (Seel et al., 2003). It is a possibility
that some of these symptoms could have altered the effectiveness of the smoking
cessation intervention. Cognitive impairment is often times an outcome to TBI which
may impact a person’s overall functioning (Schretlen & Shapiro, 2003). TBI patients
often experience difficulty multitasking and so experience cognitive overwhelming which
has been described to cause irritability ranging from mild to severe (Lux, 2007). Mood
disturbances are common with TBI clients. Amanda, for example, who was currently
diagnosed with bipolar disorder, for the first half of the study engaged in a number of
verbal outbursts almost daily. Mark in the past was also diagnosed with bipolar disorder
and during the study exhibited some mild outbursts. Whether or not this was a residual
symptom of his previous diagnoses is not known. Response efforts for cognitive tasks
are high with individuals with TBI and so may have impacted participants’ abilities to
manage their smoking by following the tips presented during the initial counseling
session and performance feedbacks. Moreover impairments in executive functioning
which involve planning, monitoring, and self-correction may have impacted participants’
abilities to maintain these skills if they were actually being practiced (Lux, 2007). Taken
together, deficits in executive functioning, mood disorder and response effort may have
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contributed to the high variability that was observed throughout the study and the failure
for maintenance of CO reductions during the abstinence induction and baseline phases.
During times participants relapsed, they were provided with advice such as
delaying their first cigarette of the day to afternoon hours, smoking only half of a
cigarette or leaving the pack of cigarettes inside and staying away from other smokers. It
was also recommended that they review the power point packet that was given to them in
their initial counseling session going over tips for quitting. Amanda and Mark did
mention smoking only half a cigarette. Mark also mentioned that he usually smoked after
eating breakfast and attempted to delay his cigarette to afternoon hours. For Mark and
Amanda, delaying their first cigarette may explain the reduction in variability in their
second baseline. The extent the advice was used and helped participants overall in
reducing their smoking however is not known. For Harry during the shaping phase it
should be mentioned that it was discovered that he used the nicotine patch throughout the
shaping phase which may explain the CO reductions at the start of the shaping phase.
Study samples were taken four times a day with the first sample taken between
8 am and 9 am. High variability was identified with all participants throughout all the
conditions. Early samples tended to be much lower than later samples mainly as a result
of participants waking up. As the day progressed, with CO having a half-life of 4-5
hours, levels may have increased partly as a result of carry over effects. However the
number of cigarettes that are smoked across time versus the number of cigarettes smoked
at one time may have different effects on CO level 4-5 hours later and should be
examined more closely taking into account this possibility.
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Studies that have examined the use of vouchers took samples one to two times
a day (Dallery & Glenn, 2005). Other studies have taken samples three times a day.
Participants in such cases would still have the opportunity to smoke abundantly in the
early part of the day prior to their first sample and 5-6 hours later may be able to provide
a sample that shows a reduction in CO levels. To avoid this, sampling times originally
were to be taken at 8 am, 1pm, 6 pm and 11 pm. However, this changed to a somewhat
random schedule once we tried to accommodate the changing program schedules. This
could possibly explain some of the variability. With the semi-random nature of the
sampling times one could argue that this may have prevented participants from “taking
advantage” of the system. For example if participants knew that a sample time was
coming up they may be able to time their last cigarette so that their CO level was less
than their previous reading. Because the sampling times were somewhat unpredictable
this may have reduced the likelihood of participants contacting the reinforcement
contingency and contributed to the variability that was identified throughout the study.
Motivation was assessed using the University of Rhode Island Change
Assessment Scale (URICA) which assesses readiness to change along four stages precontemplation, contemplation, action, and maintenance, and was developed by
researchers without a behavior analytic background (Henderson, Saules, & Galen, 2004).
Motivation may have been better addressed using a functional approach that identifies
controlling variables to smoking. Little research has been conducted that has
incorporated the use of functional assessments for smoking. Dallery, Glenn, and Raiff
(2007) developed the University of Florida Functional Assessment Scale for Smoking
(UFFAS) which is a 45 item questionnaire in which the participant rates the frequency of
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reasons for smoking along a continuum from never to always and also rates the degree to
which they agree with their response from strongly disagree to strongly agree. The
questionnaire provides questions that address controlling variables within a behavior
analytic paradigm. Understanding the controlling variables better could have provided
much more individualized tips for quitting and may have been a more effective approach
for individuals with TBI. Cole and Bonem (2000) incorporated a functional assessment
with two undergraduate students and developed individualized self-management
strategies that led to significant reductions in exhaled CO levels with both participants.
The participants in the current study often times were unable to contact
reinforcement because they did not provide a lower sample of CO. In many cases
participants were close to achieving their goal and achieving the abstinence criteria of 5
ppm or less and thus never received reinforcement. It was not until the abstinence criteria
changed to 8 ppm that consistent reductions were observed for and Mark. Giving a
margin of freedom between 5 ppm and 8 ppm could have lead to reduced variability
during the shaping and abstinence induction phases. One additional thing to consider is
that all participants had a history of substance abuse disorder. Harry was the only
participant currently attending AA meetings even though the option was still available for
Mark and Amanda. The extent of their nicotine dependency and history of drug use may
be determining factors for the effectiveness of contingency management.
For participants that fail to contact the reinforcement contingency because of
these factors percentile schedules may be more effective by increasing the likelihood of
reinforcement for gradations of improvement. Shaping procedures that have
incorporated the use of percentile schedules in which vouchers are delivered contingent
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on the participant providing a CO sample less than the last 3-7 lowest previous samples
have shown positive outcomes. Percentile schedules are designed so the participant will
contact a minimum level of reinforcement for CO reductions. This is a contrast from
other studies which have provided vouchers for specific goals or having a reduction.
Percentile schedules provide a CO window in which a participant will receive
reinforcement. Lamb, Morral, Kirby, Iguchi, and Galbicka (2004) used percentile
schedules with hard to treat individuals in three conditions: 30th, 50th, and 70th
percentile and found that greater reductions were observed with participants in the 70th
percentile.
However, if contingency management is ineffective because the value of the
money fails to compete with the reinforcing value of nicotine, a functional approach
identifying controlling stimuli may be needed. Mark reportedly may not have needed the
money because of his current income, but mentioned he still wanted to quit. For either
possibility, it is apparent that a more individualized plan that addresses the reinforcer
differences of participants and allows for participants to contact the reinforcer
contingency with minimal response effort is needed. Future research should examine the
use of percentile schedules as a shaping method and incorporate individualized
reinforcers using a functional approach. Research that incorporates the gathering of
multiple samples a day should establish random times for taking samples to minimize the
likelihood of participants circumventing the intervention. Lastly, research should solicit
the combined effort of all relevant staff members to ensure samples are not missed.
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Figure 1.. Multiple baseline design across participants showing reductions during the
shaping phase, relapses in the abstinence induction phase, and improvements for Harry
and Mark during the standard pay phase.
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Figure 2:: Craving scores as they are tracked across conditions
conditions.
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Figure 3: Total withdrawal scores across phases with items 19 summed on the MNWS.
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Table 1
University of Rhode Island Change Assessment Scores

Precontemplation Contemplation

Action

Maintenance

Amanda

11

33

25

26

Harry

7

31

25

27

Mark

17

31

32

27

Note : Scores from the URICA indicating readiness to change.
* Continuous scores (C+A+M-PC)

Table 2
Participant Earnings
Shaping

AB/IN

Standard
Pay

Bonuses

Total

$0.00

$20.00

$50.00

$89.25

Amanda $14.75

$14.00

$25.00

$50.00

$103.75

Harry $25.00

$33.00

$45.00

$50.00

$153.00

Mark $19.25

Note: Earnings across conditions and per participant
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Appendix A
Instructions for Measuring CO Levels
1) Press and hold the on/off button located on the side of the monitor until the
display becomes active then release the button.
2) Make sure to not cover the vents on the back of the device with your hand.
3) Insert a D-piece into the instrument and fit a new cardboard mouth piece.
4) Touch the icon of the person holding the monitor to begin the breath test.
5) This begins the count down. As the display counts down to zero, the participant
should inhale their breath deeply until the count reaches zero.
6) During the last 3 seconds, an audio beep will sound.
7) When the count reaches zero, the participant should begin to exhale into the
mouthpiece slowly, aiming to empty their lungs into the machine until the ppm
rises and holds at the highest level.
8) Remove and dispose of the cardboard mouth piece slowly.
9) Remove the D-piece to allow fresh air to purge the sensor then place back.
10) Show and document the correct reading.

